当前位置: X-MOL 学术Esc Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoring
ESC Heart Failure ( IF 3.8 ) Pub Date : 2021-11-04 , DOI: 10.1002/ehf2.13665
Michael Böhm 1 , Birgit Assmus 2, 3 , Stefan D Anker 4 , Folkert W Asselbergs 5 , Johannes Brachmann 6 , Marie-Elena Brett 7 , Jasper J Brugts 8 , Georg Ertl 9 , AiJia Wang 7 , Lutz Hilker 10 , Friedrich Koehler 11 , Stephan Rosenkranz 12 , David M Leistner 13 , Amr Abdin 1 , Jan Wintrich 1 , Qian Zhou 14, 15 , Philip B Adamson 7 , Christiane E Angermann 9
Affiliation  

Control of pulmonary pressures monitored remotely reduced heart failure hospitalizations mainly by lowering filling pressures through the use of loop diuretics. Sacubitril/valsartan improves heart failure outcomes and increases the kidney sensitivity for diuretics. We explored whether sacubitril/valsartan is associated with less utilization of loop diuretics in patients guided with haemodynamic monitoring in the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF).

中文翻译:

在接受远程肺动脉压监测的沙库巴曲/缬沙坦患者中较少使用袢利尿剂

远程监测的肺压控制主要通过使用袢利尿剂降低充盈压力来减少心力衰竭住院。沙库巴曲/缬沙坦可改善心力衰竭结果并增加肾脏对利尿剂的敏感性。我们探讨了在 CardioMEMS 欧洲心力衰竭监测研究 (MEMS-HF) 中,在血流动力学监测指导下,沙库巴曲/缬沙坦是否与较少使用袢利尿剂有关。
更新日期:2021-11-04
down
wechat
bug